For couples undergoing IVF, ensuring the health of the embryo is an important step toward achieving a successful pregnancy. Preimplantation Genetic Diagnosis (PGD) and Preimplantation Genetic Testing (PGT) are advanced laboratory techniques that help identify genetic abnormalities in embryos before they are transferred to the uterus. These tests can reduce the risk of passing inherited genetic disorders to the baby and improve IVF success rates for selected patients.
At Anmol Fertility Center, Jaipur, Dr. Sapna Basandani offers personalized fertility care with access to advanced genetic screening and IVF solutions, helping couples make informed reproductive choices.
PGD (Preimplantation Genetic Diagnosis) is a specialized genetic test performed on embryos created through IVF to identify specific inherited genetic disorders before embryo transfer.
PGT (Preimplantation Genetic Testing) is a broader term that refers to genetic testing of embryos to detect chromosomal abnormalities and certain inherited genetic conditions. PGT includes different types of testing based on the clinical indication.
These tests help fertility specialists select embryos with the best potential for implantation and healthy development.
PGT-A screens embryos for abnormal numbers of chromosomes, helping identify embryos with the correct chromosome count.
It is commonly recommended for:
PGT-M is performed when one or both partners carry a known inherited genetic disorder.
Examples include:
PGT-SR is recommended for couples with balanced chromosomal translocations or structural chromosome abnormalities that may increase the risk of miscarriage or unsuccessful pregnancies.
PGD/PGT may be recommended for couples who have:
Selecting genetically screened embryos may improve implantation rates in appropriate patients.
Helps reduce the likelihood of passing certain inherited diseases to future children.
Screening embryos for chromosomal abnormalities may reduce miscarriage risk related to chromosome errors.
Supports the selection of embryos with normal genetic results for transfer.
Treatment recommendations are tailored according to each couple’s medical and family history.
Eggs are collected and fertilized with sperm in the laboratory.
Embryos are cultured until the blastocyst stage.
A few cells are carefully removed from each embryo without affecting its potential for development.
The biopsy samples are analyzed in a specialized genetics laboratory.
Embryos with suitable genetic results are selected for transfer based on the overall clinical assessment.
Every couple receives a customized fertility treatment plan based on their medical history and reproductive goals.
Comprehensive fertility services including IVF, ICSI, embryo freezing, fertility preservation, and genetic testing.
Treatment recommendations follow current reproductive medicine practices and are tailored to each patient’s needs.
Our dedicated fertility team supports patients throughout every step of their parenthood journey.
No. PGD traditionally refers to testing embryos for specific inherited genetic disorders, while PGT is the broader term that includes testing for chromosomal abnormalities (PGT-A), single-gene disorders (PGT-M), and structural chromosome rearrangements (PGT-SR).
No genetic test can guarantee a completely healthy baby. These tests help identify certain chromosomal abnormalities and inherited genetic conditions but cannot detect every possible medical condition.
Embryo biopsy is a specialized procedure performed by experienced embryologists as part of advanced IVF treatment. Your fertility specialist will discuss the potential benefits and limitations for your individual situation.
These tests are generally recommended for selected couples based on age, medical history, recurrent pregnancy loss, previous IVF outcomes, or known genetic risks.